延迟高剂量甲状腺素排泄的预测因素:对于扩散型大B细胞淋巴瘤患者的实际问题
Margot Vattaire-Hervé1, Antoine Le Bozec2, Justine Clarenne3
1Department of Pharmacy, CHU Reims, F-51100, Reims, France.
概括
这项研究研究了血清白蛋白作为延迟高剂量甲状腺素消除的预测因子在扩散大B细胞淋巴瘤患者. 结果表明男性性别和更大的身体表面积与延迟清除有关,而不是专蛋白水平.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 高剂量甲状腺素 (HD-MTX) 对于中枢神经系统 (CNS) 预防和治疗扩散性大B细胞淋巴瘤 (DLBCL) 非常重要.
- 延迟消除HD-MTX可能会导致严重的毒性,需要用于患者管理的预测标记.
- 血清白蛋白已被提议作为预测HD-MTX清除的潜在生物标志物.
研究的目的:
- 评估血清白蛋白水平作为DLBCL患者延迟HD-MTX消除的预测因素的有用性.
- 确定与延迟的HD-MTX清除相关的人口和临床因素.
主要方法:
- 在2016年6月至2023年12月期间接受HD-MTX的DLBCL患者的回顾性双中心研究.
- 纳入标准:年龄大于18岁,DLBCL诊断,HD-MTX前血清白蛋白,以及血甲状腺素监测.
- 进行了单变量和多变量分析,以比较患有和没有延迟排泄的患者.
主要成果:
- 在68名患者中,有15名患者经历了延迟的HD-MTX消除.
- 男性的性别和身体表面积 (BSA) ≥2 m2与延迟清除显著相关 (分别为p=0.01和p=0.05).
- 血清白蛋白水平与延迟的HD-MTX消除没有显著关联 (p=0.8);低白蛋白症患者接受较低的MTX剂量.
结论:
- 生物识别因素,特别是男性性别和BSA,主要与延迟的HD-MTX消除有关.
- 血清白蛋白在预测延迟的HD-MTX消除中的作用仍然不确定,受到低白蛋白患者剂量调整的影响.
- 未来的研究应该考虑炎症,营养标志物和前白蛋白,以更好地预测HD-MTX毒性.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
98
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
98
Pulmonary Tuberculosis I
198
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
198
Factors Affecting Drug Response: Overview
1.6K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.6K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Renal Failure: Dose Adjustments
34
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
34
Factors Influencing Drug Absorption: Disease States and Pharmacology
338
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
338


